| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the Therapy of Primary Central Nervous System Lymphoma
|
Plotkin, Scott R.
|
|
2001
|
|
4 |
p. 263-275
13 p.
|
artikel
|
| 2 |
Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia
|
Shapira, Ilan
|
|
2004
|
|
4 |
p. 228-229
2 p.
|
artikel
|
| 3 |
Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma
|
Dean, Robert M.
|
|
2004
|
|
4 |
p. 238-249
12 p.
|
artikel
|
| 4 |
A Multicenter Trial of Infusional Etoposide, Doxorubicin, and Vincristine with Cyclophosphamide and Prednisone (EPOCH) in Patients with Relapsed Non-Hodgkin's Lymphoma
|
Wilder, Diane D.
|
|
2001
|
|
4 |
p. 285-292
8 p.
|
artikel
|
| 5 |
Atypical Lymphoid Infiltration Occurring at the Site of a Healed Varicella Zoster Infection
|
Talpur, Rakhshandra
|
|
2003
|
|
4 |
p. 253-256
4 p.
|
artikel
|
| 6 |
Autoantibody Activity in Waldenström's Macroglobulinemia
|
Stone, Marvin J.
|
|
2005
|
|
4 |
p. 225-229
5 p.
|
artikel
|
| 7 |
Best Treatment for Gastric Mucosa–Associated Lymphoid Tissue Lymphoma
|
Traullé, Catherine
|
|
2004
|
|
4 |
p. 199-200
2 p.
|
artikel
|
| 8 |
Biological Correlates of Acute Hypersensitivity Events with DAB389IL-2 (Denileukin Diftitox, ONTAK®) in Cutaneous T-Cell Lymphoma: Decreased Frequency and Severity with Steroid Premedication
|
Foss, Francine M.
|
|
2001
|
|
4 |
p. 298-302
5 p.
|
artikel
|
| 9 |
CD5, CD10, and CD23 Expression in Waldenström's Macroglobulinemia
|
Hunter, Zachary R.
|
|
2005
|
|
4 |
p. 246-249
4 p.
|
artikel
|
| 10 |
CD52 Expression in Waldenström's Macroglobulinemia: Implications for Alemtuzumab Therapy and Response Assessment
|
Owen, Roger G.
|
|
2005
|
|
4 |
p. 278-281
4 p.
|
artikel
|
| 11 |
Cell Cycle Analysis of Waldenström's Macroglobulinemia
|
Ocio, Enrique M.
|
|
2005
|
|
4 |
p. 250-252
3 p.
|
artikel
|
| 12 |
CHOP plus Rituximab Therapy in Waldenström's Macroglobulinemia
|
Treon, Steven P.
|
|
2005
|
|
4 |
p. 273-277
5 p.
|
artikel
|
| 13 |
Clinical Characteristics and Outcome of Immunoglobulin M–Related Disorders
|
Cesana, Clara
|
|
2005
|
|
4 |
p. 261-264
4 p.
|
artikel
|
| 14 |
Clinicopathologic Features of Waldenström's Macroglobulinemia and Marginal Zone Lymphoma: Are They Distinct or the Same Entity?
|
Berger, Françoise
|
|
2005
|
|
4 |
p. 220-224
5 p.
|
artikel
|
| 15 |
Cold Agglutinin Disease and Cryoglobulinemia
|
Gertz, Morie A.
|
|
2005
|
|
4 |
p. 290-293
4 p.
|
artikel
|
| 16 |
Combination of Rituximab, Cyclophosphamide, and Vincristine Induces Complete Hematologic Remission of Splenic Marginal Zone Lymphoma
|
Arcaini, Luca
|
|
2004
|
|
4 |
p. 250-252
3 p.
|
artikel
|
| 17 |
Commentary on “Advances in the Therapy of Primary Central Nervous System Lymphoma”
|
Blay, J-Y
|
|
2001
|
|
4 |
p. 276-
1 p.
|
artikel
|
| 18 |
Commentary on “Advances in the Therapy of Primary Central Nervous System Lymphoma”
|
DeAngelis, Lisa M.
|
|
2001
|
|
4 |
p. 277-
1 p.
|
artikel
|
| 19 |
Commentary on “Noninvasive Detection of Multidrug Resistance in Patients with Hematological Malignancies: Are We There Yet?”
|
Jerusalem, Guy H.M.
|
|
2002
|
|
4 |
p. 249-
1 p.
|
artikel
|
| 20 |
Commentary on “Staging and Monitoring Response to Treatment in Primary Non-Hodgkin's Lymphoma of Bone Marrow Using 18F-Fluorodeoxyglucose Positron Emission Tomography”
|
Kostakoglu, Lale
|
|
2001
|
|
4 |
p. 307-
1 p.
|
artikel
|
| 21 |
Cytogenetics of Familial Waldenström's Macroglobulinemia: In Pursuit of an Understanding of Genetic Predisposition
|
McMaster, Mary L.
|
|
2005
|
|
4 |
p. 230-234
5 p.
|
artikel
|
| 22 |
Differential Diagnosis of Waldenström's Macroglobulinemia and Other B-Cell Disorders
|
Pangalis, Gerassimos A.
|
|
2005
|
|
4 |
p. 235-240
6 p.
|
artikel
|
| 23 |
Early Results of a Phase I Trial of Oblimersen Sodium for Relapsed or Refractory Waldenström's Macroglobulinemia
|
Gertz, Morie A.
|
|
2005
|
|
4 |
p. 282-284
3 p.
|
artikel
|
| 24 |
Editorial
|
Armitage, James O.
|
|
2002
|
|
4 |
p. 200-201
2 p.
|
artikel
|
| 25 |
Efficacy of Fludarabine/Mitoxantrone/Dexamethasone Alternating with CHOP in Bulky Follicular Non-Hodgkin's Lymphoma
|
Wilder, Diane D.
|
|
2002
|
|
4 |
p. 229-237
9 p.
|
artikel
|
| 26 |
Etiology, Diagnosis, and Treatment Recommendations for Central Hypothyroidism Associated with Bexarotene Therapy for Cutaneous T-Cell Lymphoma
|
Sherman, Steven I.
|
|
2003
|
|
4 |
p. 249-252
4 p.
|
artikel
|
| 27 |
Highlights From: 43rd Annual Meeting of the American Society of Hematology; December 7–11, 2001 Orlando, Florida
|
D'Orazio, Amy I.
|
|
2002
|
|
4 |
p. 205-208
4 p.
|
artikel
|
| 28 |
Highlights From: 44th Annual Meeting of the American Society of Hematology December 7–10, 2002 Philadelphia, Pennsylvania
|
D'Orazio, Amy
|
|
2003
|
|
4 |
p. 203-208
6 p.
|
artikel
|
| 29 |
Highlights From: 45th Annual Meeting of the American Society of Hematology December 6-9, 2003 San Diego, California
|
Gibson, Angelia D.
|
|
2004
|
|
4 |
p. 206-212
7 p.
|
artikel
|
| 30 |
Immunoglobulin M Myeloma: Evaluation of Molecular Features and Cytokine Expression
|
Konduri, Kartik
|
|
2005
|
|
4 |
p. 285-289
5 p.
|
artikel
|
| 31 |
Immunophenotypic and Cytogenetic Comparison of Waldenström's Macroglobulinemia with Splenic Marginal Zone Lymphoma
|
Ocio, Enrique M.
|
|
2005
|
|
4 |
p. 241-245
5 p.
|
artikel
|
| 32 |
Initial Trials of Anti-CD80 Monoclonal Antibody (Galiximab) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma
|
Younes, Anas
|
|
2003
|
|
4 |
p. 257-259
3 p.
|
artikel
|
| 33 |
Iodine-131 Tositumomab (Bexxar®) in Relapsed/Refractory Non-Hodgkin's Lymphoma: Update from the 2001 American Society of Hematology Meeting
|
Gibson, Angelia
|
|
2002
|
|
4 |
p. 209-211
3 p.
|
artikel
|
| 34 |
Management Guidelines for Use of Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia
|
Keating, Michael
|
|
2004
|
|
4 |
p. 220-227
8 p.
|
artikel
|
| 35 |
42nd Annual Meeting of American Society of Hematology San Francisco, CA December 1–5, 2000
|
D'Orazio, Amy I.
|
|
2001
|
|
4 |
p. 251-256
6 p.
|
artikel
|
| 36 |
New Developments with Bortezomib in Treating Multiple Myeloma
|
Reddy, G. Kesava
|
|
2004
|
|
4 |
p. 215-216
2 p.
|
artikel
|
| 37 |
Nongastric Mucosa-Associated Lymphoid Tissue Lymphomas
|
Thieblemont, Catherine
|
|
2003
|
|
4 |
p. 212-224
13 p.
|
artikel
|
| 38 |
Noninvasive Detection of Multidrug Resistance in Patients with Hematological Malignancies: Are We There Yet?
|
Kostakoglu, Lale
|
|
2002
|
|
4 |
p. 242-248
7 p.
|
artikel
|
| 39 |
Origins of Waldenström's Macroglobulinemia: Does It Arise from an Unusual B-Cell Precursor?
|
Kriangkum, Jitra
|
|
2005
|
|
4 |
p. 217-219
3 p.
|
artikel
|
| 40 |
Pegylated Liposomal Doxorubicin as Single-Agent Treatment of Low-Grade Non-Hodgkin's Lymphoma: A Phase II Multicenter Study
|
Di Bella, Nicholas J.
|
|
2003
|
|
4 |
p. 235-240
6 p.
|
artikel
|
| 41 |
Phase III Study of Chlorambucil Versus Fludarabine as Initial Therapy for Waldenström's Macroglobulinemia and Related Disorders
|
Johnson, Stephen A.
|
|
2005
|
|
4 |
p. 294-297
4 p.
|
artikel
|
| 42 |
Potential Impact of a Single Nucleotide Polymorphism in the Hyaluronan Synthase 1 Gene in Waldenström's Macroglobulinemia
|
Adamia, Sophia
|
|
2005
|
|
4 |
p. 253-256
4 p.
|
artikel
|
| 43 |
Predictive Factors for Response to Rituximab in Waldenström's Macroglobulinemia
|
Dimopoulos, Meletios A.
|
|
2005
|
|
4 |
p. 270-272
3 p.
|
artikel
|
| 44 |
Prognostic Factors and Predictors of Outcome of Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance
|
Kyle, Robert A.
|
|
2005
|
|
4 |
p. 257-260
4 p.
|
artikel
|
| 45 |
Prognostic Factors for Transformation in Asymptomatic Immunoglobulin M Monoclonal Gammopathies
|
Morra, Enrica
|
|
2005
|
|
4 |
p. 265-269
5 p.
|
artikel
|
| 46 |
Progress with Alemtuzumab in Chronic Lymphocytic Leukemia: Update from the 2003 Meeting of the American Society of Hematology
|
Lee, David
|
|
2004
|
|
4 |
p. 217-219
3 p.
|
artikel
|
| 47 |
Quality-of-Life Improvements in Cutaneous T-Cell Lymphoma Patients Treated with Denileukin Diftitox (ONTAK®)
|
Duvic, Madeleine
|
|
2002
|
|
4 |
p. 222-228
7 p.
|
artikel
|
| 48 |
Recombinant Urate Oxidase for Prevention of Hyperuricemia and Tumor Lysis Syndrome in Lymphoid Malignancies
|
Ribeiro, Raul C.
|
|
2003
|
|
4 |
p. 225-232
8 p.
|
artikel
|
| 49 |
Recombinant Urate Oxidase (Rasburicase): A New Targeted Therapy for Prophylaxis and Treatment of Patients with Hematologic Malignancies at Risk of Tumor Lysis Syndrome
|
Cairo, Mitchell S.
|
|
2003
|
|
4 |
p. 233-234
2 p.
|
artikel
|
| 50 |
Report of the Third International Workshop on Waldenström's Macroglobulinemia
|
Treon, Steven P.
|
|
2005
|
|
4 |
p. 215-216
2 p.
|
artikel
|
| 51 |
Rituximab Plus CHOP is Superior to CHOP Alone for Aggressive Diffuse Large B-Cell Lymphoma: Interim Results of a GELA Phase III Trial
|
D'Orazio, Amy I.
|
|
2001
|
|
4 |
p. 257-258
2 p.
|
artikel
|
| 52 |
Staging and Monitoring Response to Treatment in Primary Non-Hodgkin's Lymphoma of Bone Marrow Using 18F-Fluorodeoxyglucose Positron Emission Tomography
|
Matthies, Alexander
|
|
2001
|
|
4 |
p. 303-306
4 p.
|
artikel
|
| 53 |
Stem Cell Transplantation for Hodgkin's Disease: A Review of the Literature
|
Carella, Angelo M.
|
|
2002
|
|
4 |
p. 212-221
10 p.
|
artikel
|
| 54 |
Testicular Lymphoma: A Literature Review and Report of a Case with a Zoster-Like Cutaneous Recurrence
|
Ingram, Richard M.
|
|
2002
|
|
4 |
p. 238-241
4 p.
|
artikel
|
| 55 |
Thalidomide: A Step Forward in the Treatment Malignant Monoclonal Gammopathies
|
Bladé, Joan
|
|
2003
|
|
4 |
p. 247-248
2 p.
|
artikel
|
| 56 |
The French ACVBP Regimen Improves Event-Free Survival for Poor Prognosis Patients with Aggressive NHL as Compared to Standard CHOP
|
D'Orazio, Amy I.
|
|
2001
|
|
4 |
p. 259-260
2 p.
|
artikel
|
| 57 |
The Influence of Advanced Age on the Treatment and Prognosis of Diffuse Large-Cell Lymphoma (DLCL)
|
Bertini, Marilena
|
|
2001
|
|
4 |
p. 278-284
7 p.
|
artikel
|
| 58 |
Tolerability and Efficacy of Thalidomide for the Treatment of Patients with Light Chain–Associated (AL) Amyloidosis
|
Seldin, David C.
|
|
2003
|
|
4 |
p. 241-246
6 p.
|
artikel
|
| 59 |
Update on the Activity of Rituximab/CHOP Combinations in Non-Hodgkin's Lymphoma
|
Gibson, Angelia D.
|
|
2003
|
|
4 |
p. 209-211
3 p.
|
artikel
|
| 60 |
Update on the Proteasome Inhibitor Bortezomibin Hematologic Malignancies
|
Goy, Andre
|
|
2004
|
|
4 |
p. 230-237
8 p.
|
artikel
|
| 61 |
Weekly x 4 Induction Therapy with the Anti-CD20 Antibody Rituximab: Effect on Circulating t(14;18)+ Follicular Lymphoma Cells
|
Pichert, Gabriella
|
|
2001
|
|
4 |
p. 293-297
5 p.
|
artikel
|
Tijdschrift beschrijving